Scientists have developed an innovative targeted therapy for aggressive forms of breast cancer that specifically affects tumor cells while sparing healthy tissues. This is a significant breakthrough for patients for whom chemotherapy is no longer effective. The therapy has reduced disease progression by 50% and, in some cases, completely halted it.
Aggressive forms of breast cancer are among the most challenging diseases to manage, especially when the patient is already undergoing chemotherapy but the tumor continues to progress. In such cases, conventional treatments often fail, limiting options for doctors and diminishing hope for patients.
To address this problem, a new targeted therapy, a combination of olaparib and carboplatin, was created. This combination directly inhibits the mechanisms that promote the growth and survival of cancer cells.
Research conducted by the University of Cambridge and other research groups has shown this approach to be highly effective because the drugs combat what are called “transcriptional dependencies.” Simply put, they block the genes that help tumor cells grow and develop. This is precisely why the treatment is targeted specifically against the tumor and has minimal impact on healthy tissues.
What Makes This Method Stand Out?
It acts only on cancer cells, protecting healthy tissues.
It’s easier for patients to tolerate compared to chemotherapy.
It can be combined with other treatment methods, making the process more effective.
More than 300 patients participated in the study. According to the results, this therapy reduced disease progression by 50%, and in some cases, the tumor completely stopped growing. This means patients have a real chance for better outcomes and to continue their lives free of the disease.
Scientists believe this innovation opens a new chapter in treatment, especially for those who have exhausted traditional methods and are seeking better alternatives.
Sources
Brooks, M. L., et al. (2025). A dual-drug combination therapy targeting transcriptional addiction in treatment-resistant breast cancer. Nature Communications, 16, Article 59151.
University of Cambridge. (2025). New approach to treating aggressive breast cancers shows significant improvement in survival. cam.ac.uk/research/news/…
